Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Biotie Therapies Inc.
During Part A, each patient will participate for up to 30 weeks, which includes a Screening Period of 1 to ≤ 6 weeks, followed by a Baseline Visit and 24 weeks of double-blind treatment: * Screening Period: 1 - 6 weeks. * Double-Blind Treatment Period: 24 weeks. After completion of Part A, patients will continue in Part B for an additional 56 weeks: * Open-Label Treatment Period: 52 weeks. * Post-Treatment Safety Follow Up: 4 weeks.
Age
30–80
Sex
ALL
Healthy volunteers
Not accepted
